Joseph Jubin, Patterson Tiffany, Arri Satpal, McConkey Hannah, Redwood Simon R
King's College London British Heart Foundation Centre of Excellence, The Rayne Institute, St. Thomas' Hospital Campus, London, UK.
Interv Cardiol. 2016 May;11(1):39-43. doi: 10.15420/icr.2016.11.1.39.
Cardiogenic shock complicates approximately 5-10 % of all MI events and remains the most common cause of death among MI cases. Over the past few decades, the mortality rate associated with cardiogenic shock has decreased with the introduction of early revascularisation, although there are limited data for patients with triple-vessel disease and left main stem disease. In more recent years, there have been a number of advances in the mechanical circulatory support devices that can help improve the haemodynamics of patients in cardiogenic shock. Despite these advances, together with progress in the use of inotropes and vasopressors, cardiogenic shock remains associated with high morbidity and mortality rates. This review will outline the management of cardiogenic shock complicating acute MI with a smajor focus on revascularisation techniques and the use of mechanical circulatory support devices.
心源性休克约使5%-10%的急性心肌梗死（MI）事件复杂化，并且仍然是MI病例中最常见的死亡原因。在过去几十年中，随着早期血运重建的引入，与心源性休克相关的死亡率有所下降，尽管关于三支血管病变和左主干病变患者的数据有限。近年来，机械循环支持设备取得了许多进展，有助于改善心源性休克患者的血流动力学。尽管有这些进展，以及在使用正性肌力药和血管升压药方面取得的进步，但心源性休克仍然与高发病率和死亡率相关。本综述将概述并发急性MI的心源性休克的管理，主要侧重于血运重建技术和机械循环支持设备的使用。
